KALA BIO, Inc. Quarterly Interest Expense in USD from Q2 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
KALA BIO, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2016 to Q1 2024.
  • KALA BIO, Inc. Interest Expense for the quarter ending March 31, 2024 was $1.46M, a 1.29% decline year-over-year.
  • KALA BIO, Inc. Interest Expense for the twelve months ending March 31, 2024 was $5.8M, a 13.6% decline year-over-year.
  • KALA BIO, Inc. annual Interest Expense for 2023 was $5.81M, a 20% decline from 2022.
  • KALA BIO, Inc. annual Interest Expense for 2022 was $7.27M, a 13.3% decline from 2021.
  • KALA BIO, Inc. annual Interest Expense for 2021 was $8.38M, a 2.43% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5.8M $1.46M -$19K -1.29% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $5.81M $1.47M -$109K -6.91% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $5.92M $1.46M +$12K +0.83% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $5.91M $1.41M -$794K -36% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $6.71M $1.47M -$561K -27.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $7.27M $1.58M -$499K -24% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $7.77M $1.45M -$625K -30.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $8.39M $2.21M +$116K +5.55% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $8.27M $2.04M -$106K -4.95% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $8.38M $2.08M -$94K -4.33% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-03
Q3 2021 $8.47M $2.07M -$85K -3.94% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $8.56M $2.09M -$43K -2.02% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $8.6M $2.14M +$13K +0.61% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $8.59M $2.17M +$25K +1.17% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $8.56M $2.16M -$23K -1.06% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $8.59M $2.13M +$73K +3.54% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $8.51M $2.13M +$34K +1.62% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $8.48M $2.15M +$44K +2.09% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $8.44M $2.18M +$1.75M +405% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $6.69M $2.06M +$1.65M +398% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $5.04M $2.09M +$1.73M +471% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $3.31M $2.1M +$1.7M +424% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-12
Q3 2018 $1.61M $432K +$220K +104% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.39M $414K +$206K +99% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $1.19M $367K +$169K +85.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $1.02M $401K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 $212K +$26K +14% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $208K +$22K +11.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $198K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q3 2016 $186K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $186K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.